Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

0.805

Today's Change

-0.015 (1.82%)

Day's Change

0.791 - 0.85

Trading Volume

2,017,551

Overview

Market Cap

290 Million

Shares Outstanding

361 Million

Avg Volume

3,234,778

Avg Price (50 Days)

1.50

Avg Price (200 Days)

1.84

PE Ratio

-1.09

EPS

-0.74

Earnings Announcement

10-Mar-2025

Previous Close

0.82

Open

0.81

Day's Range

0.791 - 0.8499

Year Range

0.73 - 3.73

Trading Volume

2,025,503

Price Change Highlight

1 Day Change

-1.87%

5 Day Change

7.32%

1 Month Change

-56.73%

3 Month Change

-53.20%

6 Month Change

-52.37%

Ytd Change

-49.38%

1 Year Change

-26.83%

3 Year Change

-82.73%

5 Year Change

-77.20%

10 Year Change

-88.73%

Max Change

-99.39%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment